The Effect of Bromelain on CD4+ T Cell Function in Asthma

菠萝蛋白酶对哮喘 CD4 T 细胞功能的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): This proposal describes a development award for Dr. Secor, a Naturopathic Physician and Licensed Acupuncturist, to successfully achieve his long term career goals of becoming an independent investigator focused on the immunomodulatory effects of natural products through translational research. This proposal combines advanced academics, research training, outstanding mentorship and consultation to promote professional career development. Dr. Secor has successfully completed a NIH/NCCAM F32 Post Doctoral Fellowship at the University of Connecticut Health Center in the Department of Immunology. His research has demonstrated that Bromelain (Br), a pineapple extract, exerted anti-inflammatory and immunomodulatory effects in an ovalbumin (OVA)-induced mouse model of allergic airway disease (AAD) via reduced CD4+ T cells, eosinophils, and Th2 cytokines. We have observed that Br treatment reduces CD25, a key activation marker on CD4+ T cells as well as alters MHC-II and CD86 levels on antigen presenting cells (APCs), such as Dendritic Cells (DCs) and B cells. We hypothesize that the therapeutic benefits of Br in this OVA-induced model occur via immunomodulatory effects on CD4+ T cells specifically by: 1) Direct inhibition of CD4+ T cell activation via IL-2 signaling, 2) Direct inhibition of antigen presenting cells (DCs and B cells). Specific Aim 1 will determine the in vivo effects of Br treatment on CD4+ T cells and APCs in local compartments (BAL, lung tissue, hilar lymph nodes) and systemic compartments (inguinal lymph nodes, spleen) at each of the 4 stages of the OVA model: Sensitization, AAD, Continuous LIT and Discontinuous AAD. Specific Aim 2 will determine the specific mechanism(s) of action of Br by in vitro treatment of CD4+ T cells, DCs and B cells isolated from local and systemic compartments during the 4 stages of the OVA model. Botanicals with unknown mechanisms of action are widely used by the general public in the treatment and management of acute and chronic conditions such as allergy and asthma. The effect of botanicals and their extracts on the immune system is an exciting new area of research. These studies will help elucidate the anti-inflammatory mechanism(s) of action of Br and provide rigorous advanced training to a CAM clinician, all of which are directly relevant to the mission of NCCAM.
描述(由申请人提供):本提案描述了自然疗法医师和持牌针灸师Secor博士的发展奖,以成功实现其长期职业目标,即通过转化研究成为专注于天然产品免疫调节作用的独立研究者。这项建议结合了先进的学术,研究培训,优秀的导师和咨询,以促进专业的职业发展。Secor博士已成功完成了NIH/NCCAM F32博士后奖学金在康涅狄格州健康中心的免疫学系的大学。他的研究表明,菠萝蛋白酶(Br),菠萝提取物,通过减少CD 4 + T细胞,嗜酸性粒细胞和Th 2细胞因子,在卵清蛋白(OVA)诱导的过敏性气道疾病(AAD)小鼠模型中发挥抗炎和免疫调节作用。我们观察到溴处理降低了CD 4 + T细胞上的关键活化标志物CD 25,并改变了抗原递呈细胞(APC)(例如树突状细胞(DC)和B细胞)上的MHC-II和CD 86水平。我们假设Br在这种OVA诱导的模型中的治疗益处通过对CD 4 + T细胞的免疫调节作用而发生,具体通过:1)通过IL-2信号传导直接抑制CD 4 + T细胞活化,2)直接抑制抗原呈递细胞(DC和B细胞)。具体目标1将确定在OVA模型的4个阶段(致敏、AAD、连续LIT和不连续AAD)中,Br处理对局部隔室(BAL、肺组织、肺门淋巴结)和全身隔室(腹股沟淋巴结、脾脏)中CD 4 + T细胞和APC的体内影响。具体目标2将通过在OVA模型的4个阶段期间体外处理从局部和全身隔室分离的CD 4 + T细胞、DC和B细胞来确定Br的具体作用机制。具有未知作用机制的植物药被公众广泛用于治疗和管理急性和慢性疾病,如过敏和哮喘。植物及其提取物对免疫系统的影响是一个令人兴奋的新研究领域。这些研究将有助于阐明Br的抗炎作用机制,并为CAM临床医生提供严格的高级培训,所有这些都与NCCAM的使命直接相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Richard Secor其他文献

Eric Richard Secor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Richard Secor', 18)}}的其他基金

The Effect of Bromelain on CD4+ T Cell Function in Asthma
菠萝蛋白酶对哮喘 CD4 T 细胞功能的影响
  • 批准号:
    7805651
  • 财政年份:
    2008
  • 资助金额:
    $ 13.46万
  • 项目类别:
The Effect of Bromelain on CD4+ T Cell Function in Asthma
菠萝蛋白酶对哮喘 CD4 T 细胞功能的影响
  • 批准号:
    8250287
  • 财政年份:
    2008
  • 资助金额:
    $ 13.46万
  • 项目类别:
The Effect of Bromelain on CD4+ T Cell Function in Asthma
菠萝蛋白酶对哮喘 CD4 T 细胞功能的影响
  • 批准号:
    8063573
  • 财政年份:
    2008
  • 资助金额:
    $ 13.46万
  • 项目类别:
The Effect of Bromelain on CD4+ T Cell Function in Asthma
菠萝蛋白酶对哮喘 CD4 T 细胞功能的影响
  • 批准号:
    7611975
  • 财政年份:
    2008
  • 资助金额:
    $ 13.46万
  • 项目类别:
Anti-inflammatory effects of Bromelain
菠萝蛋白酶的抗炎作用
  • 批准号:
    6860457
  • 财政年份:
    2004
  • 资助金额:
    $ 13.46万
  • 项目类别:
Anti-inflammatory effects of Bromelain
菠萝蛋白酶的抗炎作用
  • 批准号:
    7022281
  • 财政年份:
    2004
  • 资助金额:
    $ 13.46万
  • 项目类别:
Anti-inflammatory effects of Bromelain
菠萝蛋白酶的抗炎作用
  • 批准号:
    6742068
  • 财政年份:
    2004
  • 资助金额:
    $ 13.46万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 13.46万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了